Topic: Eli Lilly

Zepbound, one of the wildly popular weight-loss drugs that millions of Americans now take, eased sleep apnea in obese adults in two company trials, drug maker Eli Lilly announced Wednesday.

Drugmaker Eli Lilly & Co is announcing a temporary shortage of two of its insulin products.

Blockbuster weight-loss medication Zepbound (tirzepatide) appears to help folks quickly shed pounds regardless of how overweight they are, or how long they've lived being overweight or obese.

Instead of approving the new Alzheimer's drug donanemab this month, as was expected, the U.S. Food and Drug Administration will now require the experimental medication be scrutinized more closely by an expert panel.

The weight-loss drug Zepbound provides more health benefits than dropping pounds and controlling diabetes, a new study shows.

Folks who take the blockbuster weight-loss med tirzepatide (Zepbound) may regain much of the weight they lost soon after discontinuing it, new research shows.

The newly approved weight-loss medication known as Zepbound is now available for patients to take, drugmaker Eli Lilly announced Tuesday.

Retatrutide, an experimental weight-loss drug that could compete against blockbusters Wegovy and Zepbound, may work wonders for obese folks with liver disease, new research shows.

A new trial demonstrates the power of the diabetes drug Mounjaro in fighting obesity, helping folks who used the medication lose about 60 pounds.

Eli Lilly on Wednesday announced Mike Mason, executive vice president and president of Lilly's diabetes and obesity division has retired.